Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
171.50
-0.50 (-0.29%)
Apr 2, 2025, 10:51 AM CST
TPEX:6712 Revenue
In the year 2024, Ever Supreme Bio Technology had annual revenue of 933.81M TWD with 23.13% growth. Ever Supreme Bio Technology had revenue of 343.92M in the quarter ending December 31, 2024, with 34.89% growth.
Revenue
933.81M
Revenue Growth
+23.13%
P/S Ratio
14.87
Revenue / Employee
n/a
Employees
n/a
Market Cap
14.03B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 933.81M | 175.42M | 23.13% |
Dec 31, 2023 | 758.39M | 130.88M | 20.86% |
Dec 31, 2022 | 627.51M | 188.67M | 42.99% |
Dec 31, 2021 | 438.84M | 368.24M | 521.61% |
Dec 31, 2020 | 70.60M | 59.78M | 552.53% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 9.73B |
Caliway Biopharmaceuticals | 44.43M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 18.58B |
Oneness Biotech | 117.93M |
Lumosa Therapeutics | 39.15M |
Pegavision | 6.82B |
Polaris Group | 107.00M |